Jason Jardine, Makoto Tsunozaki Ph.D. On August 14, 2024, the U.S. Food and Drug Administration (FDA) approved a colony stimulating factor-1 receptor (CSF-1R)-blocking antibody, NIKTIMVO ...
Interleukin-34 (IL-34) is a multifunctional cytokine that plays a pivotal role in modulating immune responses and orchestrating inflammatory processes. Initially identified as an alternative ligand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results